| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/09/2008 | CN100400103C Pharmaceutical composition |
| 07/09/2008 | CN100400101C Vaccines containing ribavirin and methods of use thereof |
| 07/09/2008 | CN100400100C Methods for preventing or attenuating patthoangiogenic conditions |
| 07/09/2008 | CN100400080C Compositions for treating and/or preventing pollinosis |
| 07/09/2008 | CN100400079C Extraction of antiviral immune matter for curing sexual disorder and its formulation |
| 07/09/2008 | CN100399928C Preparation method of yellow gumbo freeze dried powder |
| 07/08/2008 | US7396911 Preventing, treating, or ameliorating human immunodeficiency virus infection |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396842 Five-membered cyclic compounds |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester |
| 07/08/2008 | US7396818 Sulfotransferase inhibitor |
| 07/08/2008 | US7396681 Inducing an immune response by natural killer cells to increase cytolytic activity or stimulate cell proliferation by administering in or ex vivo a specific chaperone protein; treating cancerous, infectious and autoimmune diseases |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | CA2445620C Tetracyclic compounds as pde5-inhibitors |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 07/08/2008 | CA2333154C Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 07/08/2008 | CA2332876C Efavirenz compressed tablet formulation |
| 07/08/2008 | CA2301587C Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof |
| 07/08/2008 | CA2285928C Allergen formulation comprising tyrosine and 3 de-o-acylated monophosphoryl lipid a |
| 07/08/2008 | CA2218884C Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 07/08/2008 | CA2187329C Pharmaceutical formulations for treating dust mite allergy |
| 07/03/2008 | WO2008080128A1 Devices and methods for inhibiting fibrosis |
| 07/03/2008 | WO2008079924A1 Immune response modifier compositions and methods |
| 07/03/2008 | WO2008079907A1 Compositions and methods for inhibition of the jak pathway |
| 07/03/2008 | WO2008079406A2 Gene expression markers for inflammatory bowel disease |
| 07/03/2008 | WO2008079352A2 Antibodies to cd200r |
| 07/03/2008 | WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | WO2008079293A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity |
| 07/03/2008 | WO2008079095A1 Novel prostate kallikrein allergen |
| 07/03/2008 | WO2008079073A1 Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 07/03/2008 | WO2008079030A1 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 07/03/2008 | WO2008078673A1 Method for promoting immune response comprising inhibiting cd22 function in b cells |
| 07/03/2008 | WO2008078179A1 Trkb agonists for treating autoimmune disorders |
| 07/03/2008 | WO2008077355A1 Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 07/03/2008 | WO2008058033A3 Soluble epoxide hydrolase inhibitors for the treatment of rheumatoid arthritis |
| 07/03/2008 | WO2008028667A3 Use of glycolipids as adjuvants |
| 07/03/2008 | WO2008023077A3 Compositions and methods for modulating an immune response |
| 07/03/2008 | WO2008021156A3 Antibodies to il-17a |
| 07/03/2008 | WO2007136653A3 Use of a rar antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects |
| 07/03/2008 | WO2007113646A3 A pharmaceutical composition useful as an immunomodulating agent and a process for the preparation thereof |
| 07/03/2008 | WO2006082530A3 Conjugation of streptococcal capsular saccharides to carrier proteins |
| 07/03/2008 | US20080161907 Stent coated with a sustained-release drug delivery and method for use thereof |
| 07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 07/03/2008 | US20080161401 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161348 Use of pitavastatin or salt thereof to treat rheumatoid arthritis |
| 07/03/2008 | US20080161334 Macrolides |
| 07/03/2008 | US20080161328 5-Substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 07/03/2008 | US20080161287 Bicyclic compound, production and use thereof |
| 07/03/2008 | US20080161248 Methods and Compositions for Therapeutic Treatment |
| 07/03/2008 | US20080161232 C5a Receptor Antagonist |
| 07/03/2008 | US20080160613 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/03/2008 | US20080160111 Antigen stimulus for inhibiting a degranulation phase |
| 07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
| 07/03/2008 | US20080160045 Vaccines Comprising Aluminum Adjuvants and Histidine |
| 07/03/2008 | US20080160041 C-type lectin specific monoclonal antibody conjugate for use in reducing immune response to specific antigens; immunotherapy; immunosuppression; treating allergies and autoimmune diseases |
| 07/03/2008 | US20080160039 Pneumovirus NS proteins antagonize the interferon IFN response |
| 07/03/2008 | US20080160037 Novel beta-defensins |
| 07/03/2008 | US20080160036 Protein fusion for use as antagonist to V-set domain containing T cell activation inhibitor 1(B7 H4); treating rheumatoid atrhritis, cardiomyopathy, skin, liver and connective tissue disorders |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/03/2008 | US20080160016 Compositions and methods of tolerizing a primate to an antigen |
| 07/03/2008 | US20080159996 Using zinc finger protein nuclease as therapeutic tool in treatment and prevention of viral infection |
| 07/03/2008 | US20080159977 Modified, protease resistant, colony stimulating factor for use in treatment and prevention of autoimmune and cell proliferative diseases; directed protein evolution |
| 07/03/2008 | CA2832111A1 Antibodies and methods for making and using them |
| 07/03/2008 | CA2676185A1 Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 07/03/2008 | CA2673725A1 Antibodies and methods for making and using them |
| 07/03/2008 | CA2673522A1 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 07/03/2008 | CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | CA2673410A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity |
| 07/03/2008 | CA2673366A1 Novel prostate kallikrein allergen |
| 07/03/2008 | CA2673282A1 Antibodies to cd200r |
| 07/03/2008 | CA2672916A1 Cd44 antibodies |
| 07/03/2008 | CA2672750A1 Trkb agonists for treating autoimmune disorders |
| 07/03/2008 | CA2668159A1 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| 07/02/2008 | EP1939295A1 Vaccine compostions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/02/2008 | EP1939278A1 Method for production of t cell population |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1939202A1 Novel adenine compound |
| 07/02/2008 | EP1939201A1 Novel adenine compound |
| 07/02/2008 | EP1939200A1 Novel adenine compound |
| 07/02/2008 | EP1939199A1 Novel adenine compound |
| 07/02/2008 | EP1939198A1 Novel adenine compound |
| 07/02/2008 | EP1939175A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 07/02/2008 | EP1938824A1 Medicine, food and drink or feed containing sphingomyelin |
| 07/02/2008 | EP1938817A2 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 07/02/2008 | EP1937812A2 Methods and compositions for treating immune disorders |
| 07/02/2008 | EP1937802A1 THE USE OF siRNAs IN ORGAN STORAGE/REPERFUSION SOLUTIONS |
| 07/02/2008 | EP1937723A1 Modified chaperonin 10 |
| 07/02/2008 | EP1937690A1 Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 07/02/2008 | EP1937311A2 Methods and compositions for modulating immune tolerance |
| 07/02/2008 | EP1937279A2 Use of inhibitors of pi3k-c2a for the treatment of apoptosis-related disorders |
| 07/02/2008 | EP1533313B1 Novel flavone c-glycoside derivatives and composition containing the derivatives |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |